Most cited papers from Inova Health System

Inova Health System

What are the most cited papers from Inova Health System?

The most cited paper from Inova Health System is "Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes" (Zobair M. Younossi, Aaron B. Koenig, Dinan Abdelatif et al., 2015), with 11,032 citations. Next come "The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review" (3,297) and "A multisociety Delphi consensus statement on new fatty liver disease nomenclature" (3,191).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 58 papers. Every paper with more than 340 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes Zobair M. Younossi, Aaron B. Koenig, Dinan Abdelatif et al. · Hepatology	28 Dec 2015	11,032
2	The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review Zobair M. Younossi, Pegah Golabi, James M. Paik et al. · Hepatology ReviewOpen access	3 Jan 2023	3,297
3	A multisociety Delphi consensus statement on new fatty liver disease nomenclature Mary Eugenia Rinella et al. · Hepatology Open access	22 Jun 2023	3,191
4	Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults Gregory C. Vernon, Ancha V. Baranova, Zobair M. Younossi · Alimentary Pharmacology & Therapeutics ReviewOpen access	30 May 2011	3,117
5	The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis Zobair M. Younossi, Pegah Golabi, Leyla de Avila et al. · Journal of Hepatology Review	4 Jul 2019	2,275
6	Non-alcoholic fatty liver disease – A global public health perspective Zobair M. Younossi · Journal of Hepatology Open access	9 Nov 2018	2,201
7	Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Zobair M. Younossi, Frank Tacke, Marco A. Arrese et al. · Hepatology Open access	4 Sep 2018	1,898
8	Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States Robert J. Wong, María Emilia Fernández Aguilar, Ramsey C Cheung et al. · Gastroenterology Open access	24 Nov 2014	1,848
9	The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe Zobair M. Younossi, Deirdre B Blissett, Robert Blissett et al. · Hepatology Open access	20 Aug 2016	1,318
10	Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C Gary L. Davis, Rafael Esteban, Vinod K. Rustgi et al. · New England Journal of Medicine Open access	19 Nov 1998	1,299
11	Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial Zobair M. Younossi et al. · The Lancet Open access388 authors	Dec 2019	1,260
12	Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008 Zobair M. Younossi, Maria A. Stepanova, Mariam Afendy et al. · Clinical Gastroenterology and Hepatology	25 Mar 2011	1,080
13	American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings Kenneth J. Cusi, Scott D. Isaacs, Diana Barb et al. · Endocrine Practice	May 2022	1,005
14	A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism Gregory Piazza et al. · JACC: Cardiovascular Interventions Open access	Aug 2015	943
15	Epidemiology of metabolic dysfunction-associated steatotic liver disease Zobair M. Younossi, Markos Kalligeros, Linda Henry · Clinical and Molecular Hepatology Open access	19 Aug 2024	866
16	Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates Zobair M. Younossi, Maria A. Stepanova, Janus P. Ong et al. · Clinical Gastroenterology and Hepatology Open access	14 Jun 2018	816
17	Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009 Zobair M. Younossi, Munkhzul Otgonsuren, Linda L Henry et al. · Hepatology	14 Aug 2015	815
18	Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD James M. Paik, Pegah Golabi, Youssef Younossi et al. · Hepatology	11 Feb 2020	810
19	Practice Guidelines for the Diagnosis and Management of Group A Streptococcal Pharyngitis Alan L. Bisno, Michael A. Gerber, Jack M. Gwaltney et al. · Clinical Infectious Diseases	15 Jul 2002	776
20	Advancing the global public health agenda for NAFLD: a consensus statement Jeffrey Victor Lazarus et al. · Nature Reviews Gastroenterology & Hepatology ReviewOpen access221 authors	27 Oct 2021	768
21	Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver Nila Rafiq, Chunhong Bai, Yun Hua Fang et al. · Clinical Gastroenterology and Hepatology	9 Nov 2008	739
22	Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease Janus P. Ong, Angela Pitts, Zobair M. Younossi · Journal of Hepatology	10 Jul 2008	646
23	Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality Zobair M. Younossi, Maria A. Stepanova, Nila Rafiq et al. · Hepatology	Mar 2011	641
24	Sarcopenia and Cardiovascular Diseases Abdulla A. Damluji, Maha Alfaraidhy, Noora Alhajri et al. · Circulation Open access	15 May 2023	639
25	Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States Zobair M. Younossi, Maria A. Stepanova, Janus P. Ong et al. · Clinical Gastroenterology and Hepatology	9 Jun 2020	585
26	Nonalcoholic Fatty Liver Disease in Lean Individuals in the United States Zobair M. Younossi, Maria A. Stepanova, Francesco Negro et al. · Medicine	Nov 2012	576
27	Epidemiology of chronic liver diseases in the USA in the past three decades Zobair M. Younossi, Maria A. Stepanova, Youssef Younossi et al. · Gut	31 Jul 2019	568
28	Evidence-Based Assessment of Genes in Dilated Cardiomyopathy Elizabeth Jordan et al. · Circulation Open access	5 May 2021	538
29	Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World Mehmet Sayıner, Aaron B. Koenig, Linda L Henry et al. · Clinics in Liver Disease	18 Dec 2015	537
30	Standardized Team-Based Care for Cardiogenic Shock Behnam N. Tehrani, Alexander George Truesdell, Matthew William Sherwood et al. · Journal of the American College of Cardiology Open access	Apr 2019	523
31	First detection of SARS-CoV-2 RNA in wastewater in North America: A study in Louisiana, USA Samendra P. Sherchan, Shalina A. Shahin, Lauren M. Ward et al. · The Science of The Total Environment Open access	30 Jun 2020	517
32	The global positioning system J.G. McNeff · IEEE Transactions on Microwave Theory and Techniques	Mar 2002	508
33	AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review Zobair M. Younossi, Kathleen E. Corey, Joseph K. Lim · Gastroenterology	9 Dec 2020	503
34	A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism Victor F. Tapson, Keith M. Sterling, Noah J. Jones et al. · JACC: Cardiovascular Interventions Open access	Jul 2018	499
35	The Global Burden of Liver Disease Zobair M. Younossi, Grace Lai‐Hung Wong, Quentin Mark Anstee et al. · Clinical Gastroenterology and Hepatology Open access	28 Apr 2023	498
36	Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial Steven E. Lipshultz, Rebecca E. Scully, Stuart R. Lipsitz et al. · The Lancet Oncology Open access	17 Sep 2010	454
37	Epidemiology and natural history of non-alcoholic fatty liver disease Yousef Fazel, Aaron B. Koenig, Mehmet Sayıner et al. · Metabolism	29 Jan 2016	449
38	Pharmacological Therapy for Acute Spinal Cord Injury R. John Hurlbert, Mark N. Hadley, Beverly C. Walters et al. · Neurosurgery	16 Feb 2013	446
39	Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis Zobair M. Younossi et al. · Hepatology Open access	9 Dec 2017	433
40	Adipokines and cytokines in non‐alcoholic fatty liver disease Mohammed H. Jarrar, Ancha V. Baranova, Rochelle S. Collantes et al. · Alimentary Pharmacology & Therapeutics	10 Dec 2007	433
41	Electromagnetic Navigation Bronchoscopy for Peripheral Pulmonary Lesions: One-Year Results of the Prospective, Multicenter NAVIGATE Study Erik E. Folch et al. · Journal of Thoracic Oncology Open access105 authors	23 Nov 2018	425
42	From NAFLD to MAFLD: Implications of a Premature Change in Terminology Zobair M. Younossi, Mary Eugenia Rinella, Arun Jayant Sanyal et al. · Hepatology	16 Jun 2020	420
43	Interventions for Frailty Among Older Adults With Cardiovascular Disease Naila Ijaz, Brian J. Buta, Qian‐Li Xue et al. · Journal of the American College of Cardiology Open access	31 Jan 2022	415
44	Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation Zobair M. Younossi, Giulio Marchesini, Helena Pinto-Cortez et al. · Transplantation	18 Oct 2018	407
45	Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden Zobair M. Younossi, Haesuk Park, Linda L Henry et al. · Gastroenterology Review	27 Feb 2016	400
46	International Expert Consensus on Switching Platelet P2Y 12 Receptor–Inhibiting Therapies Dominick Joseph Angiolillo et al. · Circulation Open access	30 Oct 2017	396
47	A Standardized and Comprehensive Approach to the Management of Cardiogenic Shock Behnam N. Tehrani, Alexander George Truesdell, Mitchell A. Psotka et al. · JACC Heart Failure Open access	26 Oct 2020	395
48	The Global Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among Patients With Type 2 Diabetes Zobair M. Younossi, Pegah Golabi, Jillian Kallman Price et al. · Clinical Gastroenterology and Hepatology	21 Mar 2024	391
49	Parent-of-origin-specific signatures of de novo mutations Jakob M. Goldmann, Wendy S.W. Wong, Michele Pinelli et al. · Nature Genetics	20 Jun 2016	391
50	Carotid Artery Stenosis: Grayscale and Doppler Ultrasound Diagnosis???Society of Radiologists in Ultrasound Consensus Conference Edward G. Grant, Carol B. Benson, Gregory L. Moneta et al. · Ultrasound Quarterly	Dec 2003	369

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.